UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | G | H | I | J | K | L | M | O | P | Q | R | S | T | U | V | W | Z
Number of items: 69.


Akintonde, A; Grimes, H; Moinuddin, S; Sharma, RA; McClelland, J; Thielemans, K; (2019) EP-2067 Data driven region of interest respiratory surrogate signal extraction from CBCT data. Presented at: 38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Milan, Italy. Green open access

Attard, G; (2019) Glucocorticoid regimen options in combination with abiraterone acetate: an international, multicenter, randomized, open-label phase 2 study. JAMA Oncology (In press).

Attard, G; Conteduca, V; Wetterskog, D; (2019) A multimodal approach to outcome prediction in metastatic castration-resistant prostate cancer by integrating functional imaging and plasma DNA analysis. JCO Precision Oncology (In press).


Beaton, L; Bandula, S; Gaze, MN; Sharma, RA; (2019) How rapid advances in imaging are defining the future of precision radiation oncology. British Journal of Cancer 10.1038/s41416-019-0412-y. (In press).

Beedham, W; Peck, G; Richardson, S; Tsang, K; Fertleman, M; Shipway, D; (2019) Head injury in the elderly – an overview for the physician. Clinical Medicine , 19 (2) pp. 177-184. 10.7861/clinmedicine.19-2-177.

Bentham, RB; Bryson, K; Szabadkai, G; (2019) Biclustering Analysis of Co-regulation Patterns in Nuclear-Encoded Mitochondrial Genes and Metabolic Pathways. Cancer Metabolism , 1928 pp. 469-478. 10.1007/978-1-4939-9027-6_24.

Bilanges, B; Posor, Y; Vanhaesebroeck, B; (2019) PI3K isoforms in cell signalling and vesicle trafficking. Nature Reviews Molecular Cell Biology 10.1038/s41580-019-0129-z. (In press).


Carters, R; Cheraghchi-Bashi, A; Westhorpe, A; Yu, S; Shanneik, Y; Seraia, E; Ouaret, D; ... Sharma, RA; + view all (2019) Identification of anticancer drugs to radiosensitise BRAF-wild-type and mutant colorectal cancer. Cancer Biology & Medicine , 16 (2) pp. 234-246. 10.20892/j.issn.2095-3941.2018.0284. Green open access

Chambers, P; Jani, Y; Wei, L; Kipps, E; Forster, MD; Wong, ICK; (2019) Patient Factors and their Impact on Neutropenic Events: A Systematic review and meta-analysis. Supportive Care in Cancer , 27 (7) pp. 2413-2424. 10.1007/s00520-019-04773-6. Green open access

Chan, TA; Yarchoan, M; Jaffee, E; Swanton, C; Quezada, SA; Stenzinger, A; Peters, S; (2019) Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic. Annals of Oncology , 30 (1) pp. 44-56. 10.1093/annonc/mdy495. Green open access

Chauhan, N; Mulcahy, MF; Salem, R; Benson Iii, AB; Boucher, E; Bukovcan, J; Cosgrove, D; ... Sharma, RA; + view all (2019) TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial. JMIR Research Protocols , 8 (1) , Article e11545. 10.2196/11545. Green open access

Chung, HC; Arkenau, H-T; Lee, J; Rha, SY; Oh, D-Y; Wyrwicz, L; Kang, Y-K; ... Safran, H; + view all (2019) Avelumab (anti-PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial. Journal for ImmunoTherapy of Cancer , 7 , Article 30. 10.1186/s40425-019-0508-1. Green open access

Conteduca, V; Jayaram, A; Romero-Laorden, N; Wetterskog, D; Salvi, S; Gurioli, G; Scarpi, E; ... de Giorgi, U; + view all (2019) Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer. European Urology 10.1016/j.eururo.2018.09.049. (In press). Green open access

Crowley, C; Butler, C; Camilli, C; Hynds, R; Kolluri, KK; Janes, SM; De Coppi, P; (2019) Non-invasive longitudinal bioluminescence imaging of human mesoangioblasts in bioengineered esophagi. Tissue Engineering Part C: Methods , 25 (2) pp. 103-113. 10.1089/ten.TEC.2018.0351. Green open access


Deiss, K; Lockwood, N; Howell, M; Segeren, HA; Saunders, RE; Chakravarty, P; Soliman, TN; ... Parker, PJ; + view all (2019) A genome-wide RNAi screen identifies the SMC5/6 complex as a non-redundant regulator of a Topo2a-dependent G2 arrest. Nucleic Acids Research , 47 (6) pp. 2906-2921. 10.1093/nar/gky1295. Green open access

Dillon, MT; Grove, L; Newbold, KL; Shaw, H; Brown, NF; Mendell, J; Chen, S; ... Harrington, KJ; + view all (2019) Patritumab with Cetuximab plus Platinum-Containing Therapy in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: An Open-Label, Phase Ib Study. Clinical Cancer Research , 25 (2) pp. 487-495. 10.1158/1078-0432.CCR-18-1539.

de Bono, JS; Concin, N; Hong, DS; Thistlethwaite, FC; Machiels, J-P; Arkenau, H-T; Plummer, R; ... Lassen, U; + view all (2019) Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1-2 trial. Lancet Oncology , 20 (3) pp. 383-393. 10.1016/S1470-2045(18)30859-3. Green open access


Evans, R; Flores-Borja, F; Nassiri, S; Miranda, E; Lawler, K; Grigoriadis, A; Monypenny, J; ... Ng, T; + view all (2019) Integrin-Mediated Macrophage Adhesion Promotes Lymphovascular Dissemination in Breast Cancer. Cell Reports , 27 (7) 1967-1978.e4. 10.1016/j.celrep.2019.04.076. Green open access

Evans, TRJ; Dean, E; Molife, LR; Lopez, J; Ranson, M; El-Khouly, F; Zubairi, I; ... Kristeleit, R; + view all (2019) Phase 1 dose-finding and pharmacokinetic study of eribulin-liposomal formulation in patients with solid tumours. British Journal of Cancer , 120 pp. 379-386. 10.1038/s41416-019-0377-x. Green open access


Golan, T; Hammel, P; Reni, M; Van Cutsem, E; Macarulla, T; Hall, MJ; Park, J-O; ... Kindler, HL; + view all (2019) Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer. The New England Journal of Medicine 10.1056/NEJMoa1903387. (In press).

González-Billalabeitia, E; Conteduca, V; Wetterskog, D; Jayaram, A; Attard, G; (2019) Circulating tumor DNA in advanced prostate cancer: transitioning from discovery to a clinically implemented test. Prostate Cancer and Prostatic Diseases 10.1038/s41391-018-0098-x. (In press).

Greenwood, HE; McCormick, PN; Gendron, T; Glaser, M; Pereira, R; Maddocks, ODK; Sander, K; ... Witney, TH; + view all (2019) Measurement of tumor antioxidant capacity and prediction of chemotherapy resistance in preclinical models of ovarian cancer by positron emission tomography. Clinical Cancer Research 10.1158/1078-0432.CCR-18-3423. (In press).


Hamilton, N; Hynds, R; Gowers, K; Tait, A; Butler, C; Hopper, C; Burns, A; ... Janes, SM; + view all (2019) Using a 3D collagen matrix to deliver respiratory progenitor cells to decellularized trachea in vivo. Tissue Engineering Part C: Methods , 25 (2) pp. 93-102. 10.1089/ten.TEC.2018.0241. Green open access

Hu, X; Fujimoto, J; Ying, L; Fukuoka, J; Ashizawa, K; Sun, W; Reuben, A; ... Zhang, J; + view all (2019) Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma. Nature Communications , 10 , Article 2978. 10.1038/s41467-019-10877-8. Green open access


Ismail, Mazlina; (2019) Computational analysis of T cell receptor repertoires in health and disease. Doctoral thesis (Ph.D), UCL (University College London).


Johnstone, R; Atkinson, D; Chouhan, M; Sharma, R; McClelland, J; (2019) Free-breathing MRI of the upper abdomen assisted by motion modelling. In: Proceedings of the ISMRM 27th Annual Meeting & Exhibition. International Society for Magnetic Resonance in Medicine (ISMRM): Montréal, Canada. Green open access

Jones, GG; Del Río, IB; Sari, S; Sekerim, A; Young, LC; Hartig, N; Areso Zubiaur, I; ... Rodriguez-Viciana, P; + view all (2019) SHOC2 phosphatase-dependent RAF dimerization mediates resistance to MEK inhibition in RAS-mutant cancers. Nature Communications , 10 (1) , Article 2532. 10.1038/s41467-019-10367-x. Green open access


Kenten, C; Ngwenya, N; Gibson, F; Flatley, M; Jones, L; Pearce, S; Wong, G; ... Whelan, J; + view all (2019) Understanding care when cure is not likely for young adults who face cancer: a realist analysis of data from patients, families and healthcare professionals. BMJ Open , 9 (1) , Article e024397. 10.1136/bmjopen-2018-024397. Green open access

Kosmin, M; Ledsam, J; Romera-Paredes, B; Mendes, R; Moinuddin, S; de Souza, D; Gunn, L; ... Sharma, RA; + view all (2019) Rapid advances in auto-segmentation of organs at risk and target volumes in head and neck cancer. Radiotherapy and Oncology , 135 pp. 130-140. 10.1016/j.radonc.2019.03.004.

Kumar, N; Alfrifai, D; Kolluri, KK; Sage, EK; Ishii, Y; Guppy, N; Borg, E; ... Janes, SM; + view all (2019) Retrospective response analysis of BAP1 expression to predict the clinical activity of systemic cytotoxic chemotherapy in mesothelioma. Lung Cancer , 127 pp. 164-166. 10.1016/j.lungcan.2018.12.004.

Kyte, D; Retzer, A; Ahmed, K; Keeley, T; Armes, J; Brown, JM; Calman, L; ... Calvert, M; + view all (2019) Systematic Evaluation of Patient-Reported Outcome Protocol Content and Reporting in Cancer Trials. Journal of the National Cancer Institute 10.1093/jnci/djz038. (In press). Green open access


Lancia, C; Anninga, J; Spitoni, C; Sydes, MR; Whelan, J; Hogendoorn, PCW; Gelderblom, H; (2019) Method to measure the mismatch between target and achieved received dose intensity of chemotherapy in cancer trials: a retrospective analysis of the MRC BO06 trial in osteosarcoma. BMJ Open , 9 (5) , Article e022980. 10.1136/bmjopen-2018-022980. Green open access

Lancia, C; Anninga, JK; Sydes, M; Spitoni, C; Whelan, J; Hogendoorn, PCW; Gelderblom, H; (2019) A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup. Cancer Chemotherapy and Pharmacology 10.1007/s00280-019-03797-3. (In press). Green open access

Lechner, M; Breeze, CE; O'Mahony, JF; Masterson, L; (2019) Early detection of HPV-associated oropharyngeal cancer. [Letter]. Lancet , 393 (10186) p. 2123. 10.1016/S0140-6736(19)30227-2.

Lechner, M; Jones, OS; Breeze, CE; Gilson, R; (2019) Gender-neutral HPV vaccination in the UK, rising male oropharyngeal cancer rates, and lack of HPV awareness. [Letter]. Lancet Infectious Diseases , 19 (2) pp. 131-132. 10.1016/S1473-3099(18)30802-8. Green open access

Lin, CC; Arkenau, HT; Lu, S; Sachdev, J; de Castro Carpeño, J; Mita, M; Dziadziuszko, R; ... Weiss, GJ; + view all (2019) A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas. British Journal of Cancer , 121 pp. 131-138. 10.1038/s41416-019-0503-9. Green open access


Madsen, RR; Knox, RG; Pearce, W; Lopez, S; Mahler-Araujo, B; McGranahan, N; Vanhaesebroeck, B; (2019) Oncogenic PIK3CA promotes cellular stemness in an allele dose-dependent manner. Proceedings of the National Academy of Sciences of The United States of America 10.1073/pnas.1821093116. (In press). Green open access

Mak, G; Soria, J-C; Blagden, SP; Plummer, R; Fleming, RA; Nebot, N; Zhang, J; ... Arkenau, H-T; + view all (2019) A phase Ib dose-finding, pharmacokinetic study of the focal adhesion kinase inhibitor GSK2256098 and trametinib in patients with advanced solid tumours. British Journal of Cancer (120) pp. 975-981. 10.1038/s41416-019-0452-3. Green open access

McLean, BA; Patel, VB; Zhabyeyev, P; Chen, X; Basu, R; Wang, F; Shah, S; ... Oudit, GY; + view all (2019) PI3Kα Pathway Inhibition With Doxorubicin Treatment Results in Distinct Biventricular Atrophy and Remodeling With Right Ventricular Dysfunction. Journal of the American Heart Association , 8 (9) , Article e010961. 10.1161/JAHA.118.010961. Green open access

Messaoudene, M; Mourikis, TP; Michels, J; Fu, Y; Bonvalet, M; Lacroix-Trikki, M; Routy, B; ... Zitvogel, L; + view all (2019) T cell Bispecific Antibodies in Node-Positive Breast Cancer: Novel Therapeutic Avenue for MHC class I Loss Variants. Annals of Oncology 10.1093/annonc/mdz112. (In press).

Moore, DA; Kushnir, M; Mak, G; Winter, H; Curiel, T; Voskoboynik, M; Moschetta, M; ... Arkenau, HT; + view all (2019) Prospective analysis of 895 patients on a UK Genomics Review Board. ESMO Open , 4 (2) , Article e000469. 10.1136/esmoopen-2018-000469. Green open access

Mourikis, TP; Benedetti, L; Foxall, E; Temelkovski, D; Nulsen, J; Perner, J; Cereda, M; ... Ciccarelli, FD; + view all (2019) Patient-specific cancer genes contribute to recurrently perturbed pathways and establish therapeutic vulnerabilities in esophageal adenocarcinoma. Nature Communications , 10 (1) , Article 3101. 10.1038/s41467-019-10898-3. Green open access


Ogunlade, O; Ho, J; Kalber, T; Hynds, R; Zhang, E; Janes, SM; Birchall, M; ... Beard, P; + view all (2019) Monitoring neovascularization and integration of decellularized human scaffolds using photoacoustic imaging. Photoacoustics , 13 pp. 76-84. 10.1016/j.pacs.2019.01.001. (In press). Green open access


Parry, MA; Srivastava, S; Ali, A; Cannistraci, A; Antonello, J; Barros-Silva, JD; Ubertini, V; ... Baena, E; + view all (2019) Genomic Evaluation of Multiparametric Magnetic Resonance Imaging-visible and -nonvisible Lesions in Clinically Localised Prostate Cancer. European Urology Oncology , 2 (1) pp. 1-11. 10.1016/j.euo.2018.08.005. Green open access

Paz, K; Flynn, R; Du, J; Tannheimer, S; Johnson, AJ; Dong, S; Stark, A-K; ... Blazar, BR; + view all (2019) Targeting PI3Kδ Function For Amelioration of Murine Chronic Graft-Versus-Host Disease. American Journal of Transplantation 10.1111/ajt.15305. (In press).

Plesner, T; Arkenau, HT; Gay, F; Minnema, MC; Boccadoro, M; Moreau, P; Cavenagh, J; ... Richardson, PG; + view all (2019) Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study. [Letter]. British Journal of Haematology 10.1111/bjh.15879. (In press).

Primrose, JN; Fox, RP; Palmer, DH; Malik, HZ; Prasad, R; Mirza, D; Anthony, A; ... Bridgewater, J; + view all (2019) Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncology , 20 (5) pp. 663-673. 10.1016/S1470-2045(18)30915-X.


Qin, S; Finn, RS; Kudo, M; Meyer, T; Vogel, A; Ducreux, M; Macarulla, TM; ... Zhu, AX; + view all (2019) RATIONALE 301 study: tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma. Future Oncology , 15 (16) pp. 1811-1822. 10.2217/fon-2019-0097. Green open access


Richardson, S; Brian, D; Grandage, V; Hough, R; Kottaridis, P; Mansour, M; Payne, EMC; (2019) Intensive Chemotherapy Is Associated With Poor Overall Survival in Autoimmune Disease-associated Myeloid Malignancies. HemaSphere , 3 (1) , Article e164. 10.1097/HS9.0000000000000164. Green open access

Rizzo, FM; Vesely, C; Childs, A; Marafioti, T; Khan, MS; Mandair, D; Cives, M; ... Meyer, T; + view all (2019) Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours. British Journal of Cancer , 120 (3) pp. 294-300. 10.1038/s41416-018-0367-4. Green open access

Rooshenas, L; Scott, LJ; Blazeby, JM; Rogers, CA; Tilling, KM; Husbands, S; Conefrey, C; ... Wheatley, T; + view all (2019) The QuinteT Recruitment Intervention supported five randomized trials to recruit to target: a mixed-methods evaluation. Journal of Clinical Epidemiology , 106 pp. 108-120. 10.1016/j.jclinepi.2018.10.004. Green open access

Rosenthal, R; Cadieux, EL; Salgado, R; Bakir, MA; Moore, DA; Hiley, CT; Lund, T; ... TRACERx consortium, ; + view all (2019) Neoantigen-directed immune escape in lung cancer evolution. Nature 10.1038/s41586-019-1032-7. (In press).


Schiavone, F; Bathia, R; Letchmanan, K; Masters, L; Amos, C; Bara, A; Brown, L; ... Sydes, MR; + view all (2019) This is a platform alteration: a trial management perspective on the operational aspects of adaptive and platform and umbrella protocols. Trials , 20 , Article 264. 10.1186/s13063-019-3216-8. Green open access

Shah, MA; Kojima, T; Hochhauser, D; Enzinger, P; Raimbourg, J; Hollebecque, A; Lordick, F; ... Kato, K; + view all (2019) Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus. The Phase 2 KEYNOTE-180 Study. JAMA Oncology , 5 (4) pp. 546-550. 10.1001/jamaoncol.2018.5441.

Smeland, S; Ingleby, F; Many other authors, TPUTP; Whelan, J; Sydes, MR; (2019) Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 cohort. European Journal of Cancer , 109 pp. 36-50. 10.1016/j.ejca.2018.11.027. Green open access

Steele, CD; Tarabichi, M; Oukrif, D; Webster, AP; Ye, H; Fittall, M; Lombard, P; ... Pillay, N; + view all (2019) Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways. Cancer Cell , 35 (3) 441-456.e8. 10.1016/j.ccell.2019.02.002. Green open access

Stein, A; Dalton, L; Rapa, E; Bluebond-Langner, M; Hanington, L; Stein, KF; Ziebland, S; ... Yousafzai, A; + view all (2019) Communication with children and adolescents about the diagnosis of their own life-threatening condition. The Lancet , 393 (10176) pp. 1150-1163. 10.1016/S0140-6736(18)33201-X.

Strauss, VY; Shaw, R; Virdee, PS; Hurt, CN; Ward, E; Tranter, B; Patel, N; ... Mukherjee, S; + view all (2019) Study protocol: a multi-centre randomised study of induction chemotherapy followed by capecitabine ± nelfinavir with high- or standard-dose radiotherapy for locally advanced pancreatic cancer (SCALOP-2). BMC Cancer , 19 , Article 121. 10.1186/s12885-019-5307-z. Green open access


Taylor, RM; Fern, LA; Barber, J; Alvarez-Galvez, J; Feltbower, R; Morris, S; Hooker, L; ... Whelan, JS; + view all (2019) Description of the BRIGHTLIGHT cohort: the evaluation of teenage and young adult cancer services in England. BMJ Open , 9 (4) , Article e027797. 10.1136/bmjopen-2018-027797. Green open access

Taylor, SA; Mallett, S; Ball, S; Beare, S; Bhatnagar, G; Bhowmik, A; Boavida, P; ... Streamline investigators, ; + view all (2019) Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed non-small-cell lung cancer: the prospective Streamline L trial. Lancet Respiratory Medicine 10.1016/S2213-2600(19)30090-6. (In press). Green open access

Taylor, SA; Mallett, S; Beare, S; Bhatnagar, G; Blunt, D; Boavida, P; Bridgewater, J; ... Streamline investigators, ; + view all (2019) Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial. The Lancet Gastroenterology & Hepatology 10.1016/S2468-1253(19)30056-1. (In press). Green open access

Teixeira, VH; Pipinikas, CP; Pennycuick, A; Lee-Six, H; Chandrasekharan, D; Beane, J; Morris, TJ; ... Janes, SM; + view all (2019) Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions. Nature Medicine 10.1038/s41591-018-0323-0. (In press). Green open access

Tombal, B; Saad, F; Penson, D; Hussain, M; Sternberg, CN; Morlock, R; Ramaswamy, K; ... Attard, G; + view all (2019) Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncology 10.1016/S1470-2045(18)30898-2. (In press). Green open access


Uddin, I; Joshi, K; Oakes, T; Heather, JM; Swanton, C; TRACERx consortium, .; Chain, B; (2019) An Economical, Quantitative, and Robust Protocol for High-Throughput T Cell Receptor Sequencing from Tumor or Blood. Cancer Immunosurveillance: Methods and Protocols pp. 15-42. 10.1007/978-1-4939-8885-3_2.


van Dorp, L; Lowes, S; Weigel, L; Ansari-Pour, N; López, S; Mendoza-Revilla, J; Robinson, JA; ... Hellenthal, GR; + view all (2019) Genetic legacy of state centralization in the Kuba Kingdom of the Democratic Republic of the Congo. Proceedings of the National Academy of Sciences , 116 (2) pp. 593-598. 10.1073/pnas.1811211115. Green open access


White, J; Carolan-Rees, G; Dale, M; Patrick, HE; See, TC; Bell, JK; Manas, DM; ... Sharma, RA; + view all (2019) Yttrium-90 Transarterial Radioembolization for Chemotherapy-Refractory Intrahepatic Cholangiocarcinoma: A Prospective, Observational Study. Journal of Vascular and Interventional Radiology , 30 (8) pp. 1185-1192. 10.1016/j.jvir.2019.03.018.

Woodcock, HV; Eley, JD; Guillotin, D; Plate, M; Nanthakumar, CB; Martufi, M; Peace, S; ... Chambers, RC; + view all (2019) The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis. Nature Communications , 10 , Article 6. 10.1038/s41467-018-07858-8. Green open access

Wu, A; Attard, G; (2019) Plasma DNA Analysis in Prostate Cancer: Opportunities for Improving Clinical Management. Clinical Chemistry , 65 (1) 10.1373/clinchem.2018.287250.


Zhabyeyev, P; McLean, B; Chen, X; Vanhaesebroeck, B; Oudit, GY; (2019) Inhibition of PI3Kinase-α is pro-arrhythmic and associated with enhanced late Na⁺ current, contractility, and Ca²⁺ release in murine hearts. Journal of Molecular and Cellular Cardiology , 132 pp. 98-109. 10.1016/j.yjmcc.2019.05.008.

This list was generated on Sun Aug 18 04:46:44 2019 BST.